European markets started the week on an optimistic note, following the global trend, amid hopes for a possible reduction in the Federal Reserve's benchmark interest rate in December. The pan-European Stoxx 600 index rose by 0.3%, with most stock exchanges and sectors in positive territory. Bayer's shares saw a significant increase of 10.9% due to positive results in the study for the anticoagulant Asundexian. In contrast, Novo Nordisk's shares fell by 5.8% due to the failure of the substance semaglutide in an Alzheimer's study. The defense sector was negatively affected, with declines in the shares of Rheinmetall, Renk, Hensoldt, and Saab, amid peace talks between the US and Ukraine. In the US, discussions for security guarantees for Ukraine continue without a final agreement. In global markets, stock exchanges in the Asia-Pacific region and US futures advanced, with investors anticipating a possible interest rate cut of 0.25 percentage points in December, according to CME FedWatch estimates.
Sources
Latest News
23:51
Traian Băsescu criticizes Dacian Cioloș’s candidacy for the leadership of the Francophonie: “An immorality”
23:26
Jared Kushner Announces Progress in Negotiations to End the War in Ukraine
22:58
The Trump administration tightens rules on exporting U.S. chips to third countries to limit China’s access to AI technology
22:48
Zelenskyy asks European allies for missiles for Ukraine, following talks with US envoys about negotiations with Russia
22:38
Transgaz Director: The Mintia Power Plant Begins Commercial Production with the First Turbine, While the Second Enters Testing
See more news